Insider filing · AMGN
Rachna Khosla
SVP, Business Development
profile →
Amgen Inc.
AMGN · Healthcare · 48 filings in 24 months
ticker →
Rachna Khosla sold $299K of Amgen (AMGN)
Executed Nov 12 2025, disclosed Nov 13 2025, 1 day later.
Value, as filed
$299K
890 sh × $336.24
Executed
Nov 12 2025
the trade date, as filed
Disclosed
Nov 13 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RKRachna Khosla (SVP, Business Development) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amgen Inc. (AMGN). The largest single filing was $1.3M of AMGN (3,252 sh across 2 lots, as filed), executed Aug 11.
The name
AMGNHealthcare · Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rachna Khosla in AMGN
AMGNSALE
Amgen Inc.
$1.3M3,252 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 7:05 PM ET AMGNSALE Amgen Inc. $435K
1,500 sh × $289.68
Exec Jun 5 2025
Filed Jun 6 2025 · 5:30 PM ET